UPDATE: TJX Cos. (TJX) Tops Q2 EPS by 1c; Comps Up 7%; Boosts FY13 EPS Outlook, Guides Q3
Tweet
Share
E-mailGet Alerts TJX Hot Sheet
Price: $164.17 --0%
Revenue Growth %: +5.4%
Financial Fact:
Selling, general and administrative expenses: 1.46B
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +5.4%
Financial Fact:
Selling, general and administrative expenses: 1.46B
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
(Updated - August 14, 2012 8:35 AM EDT)
TJX Cos. (NYSE: TJX) reported Q213 EPS of $0.56, $0.01 better than the analyst estimate of $0.55. Sales were $5.95 billion, versus the consensus of $5.99 billion.
Comps up 7 percent.
Sees Q3 EPS of $0.56 - $0.59 and comps up 2 - 4%.
Boosts FY13 EPS Outlook to $2.39 - $2.45, from $2.38 - $2.44 and the consensus of $2.46.
For earnings history and earnings-related data on TJX Cos. (TJX) click here.
TJX Cos. (NYSE: TJX) reported Q213 EPS of $0.56, $0.01 better than the analyst estimate of $0.55. Sales were $5.95 billion, versus the consensus of $5.99 billion.
Comps up 7 percent.
Sees Q3 EPS of $0.56 - $0.59 and comps up 2 - 4%.
Boosts FY13 EPS Outlook to $2.39 - $2.45, from $2.38 - $2.44 and the consensus of $2.46.
For earnings history and earnings-related data on TJX Cos. (TJX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
- Deutsche Bank Starts Tandem Diabetes Care (TNDM) at Hold
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Guidance, Retail SalesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
